PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DDS vs. NVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DDS and NVO is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

DDS vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

0.00%20,000.00%40,000.00%60,000.00%80,000.00%100,000.00%JulyAugustSeptemberOctoberNovemberDecember
3,432.11%
60,484.46%
DDS
NVO

Key characteristics

Sharpe Ratio

DDS:

0.46

NVO:

-0.43

Sortino Ratio

DDS:

0.93

NVO:

-0.37

Omega Ratio

DDS:

1.12

NVO:

0.95

Calmar Ratio

DDS:

0.62

NVO:

-0.36

Martin Ratio

DDS:

1.33

NVO:

-1.15

Ulcer Index

DDS:

14.02%

NVO:

13.25%

Daily Std Dev

DDS:

40.33%

NVO:

35.35%

Max Drawdown

DDS:

-93.94%

NVO:

-71.30%

Current Drawdown

DDS:

-3.22%

NVO:

-41.92%

Fundamentals

Market Cap

DDS:

$6.95B

NVO:

$486.49B

EPS

DDS:

$38.76

NVO:

$2.99

PE Ratio

DDS:

11.27

NVO:

36.12

PEG Ratio

DDS:

-1.28

NVO:

1.61

Total Revenue (TTM)

DDS:

$6.67B

NVO:

$270.58B

Gross Profit (TTM)

DDS:

$2.58B

NVO:

$229.07B

EBITDA (TTM)

DDS:

$964.29M

NVO:

$135.97B

Returns By Period

In the year-to-date period, DDS achieves a 14.08% return, which is significantly higher than NVO's -16.93% return. Both investments have delivered pretty close results over the past 10 years, with DDS having a 16.48% annualized return and NVO not far ahead at 17.16%.


DDS

YTD

14.08%

1M

9.68%

6M

9.05%

1Y

17.02%

5Y*

50.27%

10Y*

16.48%

NVO

YTD

-16.93%

1M

-19.26%

6M

-39.90%

1Y

-16.95%

5Y*

26.03%

10Y*

17.16%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DDS vs. NVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DDS, currently valued at 0.46, compared to the broader market-4.00-2.000.002.000.46-0.43
The chart of Sortino ratio for DDS, currently valued at 0.93, compared to the broader market-4.00-2.000.002.004.000.93-0.37
The chart of Omega ratio for DDS, currently valued at 1.12, compared to the broader market0.501.001.502.001.120.95
The chart of Calmar ratio for DDS, currently valued at 0.62, compared to the broader market0.002.004.006.000.62-0.36
The chart of Martin ratio for DDS, currently valued at 1.33, compared to the broader market-5.000.005.0010.0015.0020.0025.001.33-1.15
DDS
NVO

The current DDS Sharpe Ratio is 0.46, which is higher than the NVO Sharpe Ratio of -0.43. The chart below compares the historical Sharpe Ratios of DDS and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
0.46
-0.43
DDS
NVO

Dividends

DDS vs. NVO - Dividend Comparison

DDS's dividend yield for the trailing twelve months is around 5.99%, more than NVO's 1.70% yield.


TTM20232022202120202019201820172016201520142013
DDS
Dillard's, Inc.
5.99%5.18%4.89%6.41%0.95%0.68%0.66%0.57%0.45%0.40%0.19%0.23%
NVO
Novo Nordisk A/S
1.70%0.99%1.18%1.34%1.86%2.12%2.47%2.12%3.93%1.31%1.96%1.72%

Drawdowns

DDS vs. NVO - Drawdown Comparison

The maximum DDS drawdown since its inception was -93.94%, which is greater than NVO's maximum drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for DDS and NVO. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-3.22%
-41.92%
DDS
NVO

Volatility

DDS vs. NVO - Volatility Comparison

The current volatility for Dillard's, Inc. (DDS) is 10.91%, while Novo Nordisk A/S (NVO) has a volatility of 20.84%. This indicates that DDS experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
10.91%
20.84%
DDS
NVO

Financials

DDS vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Dillard's, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab